Skip to main content
. 2012 Mar 13;52:82–97. doi: 10.1016/j.ejmech.2012.03.007

Table 2.

In vitro anti-plasmodial activity, cytotoxicity, resistance factor and selectivity index of compounds 10a-s.

Compound IC50 (nM)
Resistance factore ClogPf Cytotoxicity (μM)g
Selectivity indexj
CQS (3D7)a,b CQR (K1)c,d CC50h MICi
10a 21.7 139.3 6.43 6.83 1.4 0.8 10.04
10b 247.5 52.2 0.210 6.82 0.8 0.8 15.33
10c 202.3 26.1 0.129 7.35 0.9 0.8 34.41
10d 1134.9 617.7b 0.544 8.94
10e 252.2 516.4 2.047 9.47
10f 1776.8 487.7 0.2744 10.53
10g 264.8 853.7 3.22 11.58
10h 14828.3 27320.9 1.842 8.81
10i 644.4 6186.4b 9.600 8.80
10j 15888.5 28096.7 1.7683 5.31
10k 286.7 860.4b 3.00 8.28
10l 63.1 160.8 2.5480 5.64 58.2 20 361.89
10m 42.1 1659.8b 39.422 5.75 0.8 4 0.48
10n 598.7 230.5b 0.385 7.30 0.5 0.8 2.1
10o 697.2 192.1 0.2756 7.30
10p 172.9 96.0 0.5555 6.89 2.2 ≥0.8 22.90
10q 1955.1 229.3 0.1173 7.30
10r 18.2 3.6 0.2 7.30 2.3 4.0 638
10s 499.9 175.8 0.3518 7.30
2 1.4 201.8 140.39 5.1
Artesunate 5.3 2.8 0.5418 1.06
a

CQ sensitive strain.

b

primary screening.

c

CQ resistant strain.

d

secondary screening.

e

calculated by dividing IC50 values of PFK1 by PF3D7.

f

calculated from Chem draw Ultra 11.0.

g

determined on Madin Darby canine kidney (MDCK)cells.

h

50% cytotoxic concentration, as determined by measuring the cell viability with the colorimetric formazan- based MTS assay (reference drugs used: Oseltamivir carboxylate CC50/MIC >100, Ribavirin CC50/MIC >100, Amantadine CC50/MIC >200 and Rimantadine CC50/MIC >200).

i

minimum compound concentration that causes a microscopically detectable alteration of normal cell morphology.

j

Selectivity Index (S.I.) is calculated as CC50/IC50 (K1 Strain) ratio.